Clinical Trial Update: Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia [Phase 2]

View source ↗

Summary

This clinical trial update summarizes a Phase 2 study evaluating whether bupropion affects smoking behavior in individuals with schizophrenia; the trial has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia
• Tobacco Use Disorder

Drugs mentioned

• bupropion (bupropion)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Schizophrenia, Tobacco Use Disorder | Phase 2 | Status: COMPLETED